Charles Crain

Charles Crain serves as Chief Technology Officer at Artificial. Artificial operates in the biotechnology sector with approximately 35.0 employees. The company is headquartered in Austin, Texas. To date, Artificial has raised 21500000.0 in total funding, with the most recent round being Series A.

Industry & Role Insights

• • MessageCEO tracks 381 executives in the biotechnology sector.
• • We have verified contacts for 2 executives at Artificial.
• • 6,856 executive contacts are available in Texas.
• • Our database includes 201,469 c suite-level executives.

Cloudflare DNS Gmail Outlook Google Apps CloudFlare Hosting Hubspot Cloudways DigitalOcean Mapbox Mobile Friendly DoubleClick YouTube Google Dynamic Remarketing WordPress.org Wistia Google Analytics Google Tag Manager DoubleClick Conversion Linkedin Marketing Solutions Google Font API Lever Remote Python AI

automation software robotics biotechnology life sciences lab automation digital transformation augmented reality digital lab end to end workflows workflow orchestration lab of the future smart lab digital orchestration ai-driven labs laboratory workflows real-time monitoring data management liquid handling automated pipelines laboratory instruments ai integration digital twin workflow optimization assistance in labs lab operation guides data integrity compliance record keeping sample management automated data capture scheduling algorithms robotic systems cloud-based solutions system integration scientific research support remote data access collaborative lab management feedback systems automated reporting custom lab solutions professional services experiment scheduling data visualization error reduction interactive guidance user-friendly interfaces digital lab systems process automation multivendor support machine learning ai readiness automation scaling liquid handlers integration workcell management cell culture workflows adaptive systems productivity enhancement smart laboratory systems training optimization data traceability cloud services for labs scientific data analytics information technology & services mechanical or industrial engineering professional training & coaching artificial intelligence

DF

David Fuller Chief Executive Officer at Artificial

CB

Chip Baird Chief Executive Officer at 2seventy bio at 2seventy bio

JL

Jason Loveridge CEO at 4SC AG

MM

Marie Moores Chief Operating Officer at AB Cavalli Coach & Consultant

JR

Julie Rubinstein President and Chief Operating Officer at Adaptive Biotechnologies Corp.

Outreach Guidance — biotechnology Sector

Technology executives make decisions on infrastructure, tooling, and partnerships. When reaching out to Charles Crain, lead with your value proposition relative to the stack they currently use. Generic pitches perform poorly; specific technical relevance is key.

How do I reach Charles Crain directly?

Charles Crain's verified email address is available to MessageCEO Pro subscribers. They currently serve as Chief Technology Officer at Artificial. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Charles Crain work for?

Charles Crain is Chief Technology Officer at Artificial, a company in the biotechnology sector with 35.0 employees. The company is based in Austin, Texas.

Can I pitch or sell to Charles Crain?

As Chief Technology Officer at Artificial, Charles Crain is a key decision-maker in the biotechnology sector. MessageCEO Pro gives you verified email to reach Charles Crain directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Charles Crain in?

Charles Crain works in the biotechnology industry as Chief Technology Officer at Artificial. MessageCEO provides verified contact information for executives across all major industries.

Is Charles Crain's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Charles Crain's profile is kept up-to-date with the latest available information.

Last updated: May 18, 2026